Biotech

January 21st 2019

Antisense Phase II Clinical Trial now 50% enrolled and on track for completion

January 9th 2019

BPH sharpens up brain monitoring & medical marijuana efforts

January 7th 2019

Imugene onboards renowned cancer scientist Michael Caligiuri

December 17th 2018

Imugene's promising trial results: five patients with >30% decrease in tumour size

December 7th 2018

RotoGro buzzes on new strategic Affinity

November 26th 2018

BPH completes successful anaesthesia monitor trials

November 22nd 2018

ANP: Why partnering with big biotech has its benefits

November 19th 2018

Immuron appoints a new CEO to lead it into the future

November 13th 2018

Imugene's gastric cancer immuno-oncology trial advances to Phase 2

November 9th 2018

Good run continues for Imugene with $1.85M R&D tax incentive

November 1st 2018

Race Oncology pens key deal to seek chemo drug Bisantrene licensing

October 29th 2018

Prescient onboards former Array Biopharma executive